Skip to Content

Apremilast Glenmark 10 mg + 20 mg + 30 mg film-coated tablets

Licence status
Authorised: 03/10/2025
Active substances
Apremilast, Apremilast, Apremilast
Dosage Form
Film-coated tablet
Licence number
PA22645/007/001
Licence holder
Glenmark Arzneimittel GmbH

Licence information

ATC code
L04AA32 apremilast
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
*** AWAITING VALUE ***
Licence issued
03/10/2025